RxDoctor Payments Data

Vikas Bhatara, MD

Critical Care Medicine · Lake Bluff, ILNPI 1811026446

Payments from drug & device makers

$330in general payments, 2019–2025

Across 12 payments — averaging $27.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$85
  • Lilly USA, LLC$53
  • Novo Nordisk$47
  • Boehringer Ingelheim$43
  • Itamar Medical Inc$27
  • Exact Sciences$24
  • plus $52 from 3 others

What the payments were for

  • Food & beverage$330100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$330 in reported general payments places this provider in the 50th percentile of 281 critical care medicine providers in Illinois.

See all critical care medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$59,792
Medicare patients
357
Services billed
716

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter120$86,298
Spiriva HandihalerTiotropium Bromide83$57,014
Incruse ElliptaUmeclidinium Bromide78$31,297
Breo ElliptaFluticasone/Vilanterol48$22,177
Spiriva RespimatTiotropium Bromide24$17,446
Stiolto RespimatTiotropium Br/Olodaterol Hcl13$10,703
SymbicortBudesonide/Formoterol Fumarate33$10,333
Fluticasone-SalmeterolFluticasone Propion/Salmeterol62$9,197
Tiotropium Bromide11$4,401
Albuterol Sulfate HfaAlbuterol Sulfate94$2,749
Wixela InhubFluticasone Propion/Salmeterol20$2,671
Ventolin HfaAlbuterol Sulfate26$2,306
Modafinil17$949
Gabapentin17$201
Fluticasone Propionate12$130

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Incruse Ellipta, Breo Ellipta$22$139,772246 claims
Boehringer IngelheimSpiriva Respimat, Stiolto Respimat$43$28,14937 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 281 critical care medicine providers in Illinois.

Other critical care medicine in Lake Bluff

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →